B7x (B7-H4 or B7S1), a member of the B7 family, inhibits in vitro T cell proliferation and cytokine production by binding to an unidentified receptor on activated T cells, but its in vivo function remains largely unclear. We show that B7x protein was expressed in epithelial cells of the lung, but not in lymphoid tissues. To investigate the role of B7x in the lung, we determined the susceptibility of B7x-deficient (B7x 2/2 ) mice to a lethal pulmonary infection with Streptococcus pneumoniae. B7x 2/2 , but not B7-H3-deficient, mice were significantly more resistant to S. pneumoniae pulmonary infection than their wild-type (Wt) counterparts. B7x 2/2 mice had significantly lower bacterial burdens and levels of inflammatory cytokines in lungs as early as 12 h postinfection. They also had milder immunopathology that was localized in alveolar spaces, whereas Wt mice had severe inflammation that was perivascular. Control of infection in B7x 2/2 mice was associated with a marked increase in activated CD4 and CD8 T cells and fewer neutrophils in lungs, whereas the susceptible Wt mice had the opposite cellular profile. In B7x 2/2 Rag1 2/2 mice that lack T cells, reduction in bacterial burden was no longer observed. Control of S. pneumoniae and the increased survival observed was specific to the lung, because systemically infected B7x 2/2 mice were not resistant to infection. These data indicate that lungexpressed B7x negatively regulates T cells, and that in its absence, in B7x 2/2 mice, an enhanced T cell response contributed to reduced lethality in a pulmonary infection model with S.
T he B7/CD28 family is of central importance in regulating the T cell response, and affects both activation and the outcome of effector function (1, 2) . B7x (B7-H4 or B7S1) is the most recently identified member of this family, and in vitro studies show that it sends a coinhibitory signal by binding to a currently unknown receptor that is expressed on activated T cells (3) (4) (5) . Binding of B7x to its putative receptor on both CD4 and CD8 T cells inhibits cell cycle progression, proliferation, and production of associated effector cytokines such as IL-2 and IFN-g (3) (4) (5) . B7x mRNA expression is higher in peripheral nonlymphoid tissues, particularly the lung, pancreas, prostate, and testes, whereas in lymphoid tissues such as the spleen, it is comparatively low (3, 6) . This is in marked contrast with the classical B7 family members, B7-1 and B7-2, which are most highly expressed on professional APCs in lymphoid tissues (6, 7) . The pattern of B7x mRNA expression coupled with its coinhibitory signaling suggests that it may be a potent regulator of the immune response in the periphery. Murine studies support this notion as B7x protein expression is detected on the insulin-producing b cells of the pancreas, and whereas B7x knockout results in exacerbation of diabetes, overexpression of B7x in b cells abrogates development of disease (6) . Clinical data also support a coinhibitory role for B7x, because overexpression of the protein has been observed on many types of tumors and is often associated with enhanced disease progression and poor clinical outcome (8) (9) (10) (11) (12) . These clinical observations lead to a hypothesis that expression of B7x by tumors represents a previously unrecognized mechanism of downregulating antitumor T cell responses at the level of the effector cell (2, 3, 13) .
Currently, there are very limited data regarding the role of B7x in the immune response to infection, as evidenced by only two publications (14, 15) . One study shows that B7x-deficient (B7x 2/2 ) mice have a slightly stronger Th1 response and lower parasite burdens after a footpad challenge with Leishmania major (14) . Another study reveals that B7x 2/2 mice are more resistant to a lethal i.p. infection with Listeria monocytogenes, although this is attributed to an augmented neutrophil, rather than T cell, response (15) . Thus, the role of B7x in infection warrants further investigation. Because B7x mRNA expression is highly detected in the lung (3), we decided to investigate the role of this molecule in the immune response to and outcome of pulmonary infection with Streptococcus pneumoniae. S. pneumoniae is an encapsulated Gram-positive bacterium that colonizes the respiratory tract and can cause pneumonia, otitis, meningitis, and sepsis (16) . It primarily affects infants, young children, elderly adults, and immunocompromised patients, and is a major cause of death in unimmunized children younger than 5 y (17) . Although the innate immune response and the humoral arm of adaptive immunity are associated with pneumococcal clearance, new data have demonstrated an important role for T cells in the host response to infection. Mice lacking CD8 T cells are more susceptible to pulmonary infection with S. pneumoniae (18) , whereas mice lacking CD4 T cells are reported to either be more or less protected (19, 20) . In this study, we found that B7x protein was detected in epithelial cells lining the bronchial passages of the lung but not in the spleen. B7x 2/2 mice were more resistant to lethal pulmonary, but not systemic, challenge with S. pneumoniae, and had lower bacterial burdens in the lung, blood, and spleen than wild-type (Wt) controls. Wt mice had a severe inflammatory response and increased levels of associated cytokines and chemokines in their lungs, but inflammation was largely controlled in B7x mice that lack mature T cells, a reduction in bacterial burden was no longer observed and the mice had similar burdens as the susceptible Wt mice. This study suggests that B7x negatively regulates T cells in the lung, which contributes to the lethality of pulmonary S. pneumoniae infection.
Materials and Methods

Mice
B7x 2/2 and B7-H3-deficient (B7-H3 2/2 ) mice on the C57BL/6 background were previously described (6, 23) . Age-and sex-matched Wt C57BL/6 mice were purchased from the National Cancer Institute. Rag1 2/2 mice were purchased from The Jackson Laboratory and were crossed with the B7x 2/2 mice to generate the double-knockout B7x
Rag1 2/2 mice. Mice that were 7-9 wk of age were used for studies. All mice were maintained under specific pathogen-free conditions at the Albert Einstein College of Medicine following protocols approved by the Institutional Animal Care and Use Committee.
Bacteria and pneumococcal infection models
The S. pneumoniae serotype 3 (ST3) strain A66 was used in this study. A66 has been used extensively to study the pathogenesis of pneumococcal pneumonia in mice (18, 24, 25) . Bacteria were grown in Bacto Tryptic Soy Broth (TSB; Becton-Dickinson, BD) to midlog phase at 37˚C in 5% CO 2 and stored in TSB + 10% glycerol at 280˚C until use as described previously (26) . CFU count of frozen stock was determined by plating of 10-fold serial dilutions on Trypticase soy agar with 5% sheep's blood (Becton Dickinson). Dilutions were grown at 37˚C with 5% CO 2 for 18 h, at which CFU counts were determined.
Intranasal infection was performed as described previously (18) . In brief, before infection, frozen bacterial stock was thawed and diluted to the desired dose in TSB media. Mice were minimally anesthetized and intranasally infected with 1 3 10 5 CFU/40 ml/mouse by slowly pipetting 20 ml onto each nare. Mice were held upright to allow inhalation of bacteria and effective delivery to the lungs. Dose confirmation was performed by plating bacteria before and postinfection on Trypticase soy agar with 5% sheep's blood and were grown at 37˚C with 5% CO 2 for 18 h, at which CFU counts were determined.
Bacterial burden
Tissue bacterial burdens were determined as previously described (18) . Mice were deeply anesthetized, and blood was collected and kept in Eppendorf tubes with heparin to prevent coagulation. After blood collection, mice were vascularly perfused with PBS through the right ventricle of the heart to remove any remaining blood from the lungs. Whole lungs and spleen were collected and placed in sterile HBSS on ice and homogenized (Fisher Scientific PowerGen 125) for 20 s at maximum speed; 10-fold serial dilutions were plated on Trypticase soy agar with 5% sheep's blood and incubated for CFU determination.
Immunohistochemistry and histopathology
Tissues were collected from mice and fixed in 10% neutral buffered formalin (NBF) (Fisher) before paraffin embedding. After clearing in xylene washes and rehydration, Ag retrieval was performed in a vegetable steamer in Tris/EDTA Ag retrieval solution. Sections were biotin blocked using the ScyTek Biotin Blocking kit; then normal blocking was done using 2% BSA/ 5% donkey serum (Jackson ImmunoResearch). After blocking, sections were incubated with a 1:200 dilution of biotinylated anti-B7-H4 Ab or isotype IgG control (R&D Systems) overnight at 4˚C and then blocked for endogenous peroxidase for 10 min in 1% H 2 O 2 . Sections were incubated in ABC reagent (Vector Labs) for 20 min; then the tyramide amplification kit (Invitrogen) was used, followed again with the ABC reagent for 20 min. Sections were developed with the DAB kit (Vector Labs), counterstained with hematoxylin, dehydrated, cleared in xylene, and coverslipped.
For histopathological examination, lungs were inflated through the trachea using an 18G needle with 10% NBF until fully expanded, removed, and incubated overnight in 10% NBF. After fixation, lungs were transferred to 70% ethanol for at least 1 h before paraffin embedding. Sectioned tissues were stained with H&E by the Histotechnology and Comparative Pathology Core Facility and viewed with AxioCam MRc Zeiss microscope. A board-certified veterinary pathologist performed histopathological examination.
Cytokine levels in the lung, blood, and spleen Blood, lungs, and spleen were collected as described above. Blood was centrifuged and plasma was collected and stored at 280˚C until use. Lungs and spleen were homogenized as described above, centrifuged at 3000 rpm for 30 min, and homogenate supernatant was collected and stored at 280˚C until use. Cytokine levels were determined using both the mouse inflammation and Th1/Th2/Th17 BD Cytometric Bead Array kits (BD Biosciences) according to the manufacturer's instructions. The chemokines KC, MIP-1a, MIP-1b, and RANTES were detected with BD Cytometric Bead Flex Sets that were combined and analyzed according to the manufacturer's instructions.
Natural Ab detection
Bacteria were heat killed by incubation in a water bath at 65˚C for 15 min and then adhered to ELISA plates overnight. Sera from naive B7x 2/2 and Wt mice were incubated with adhered bacteria. Anti-IgM-HRP and anti-IgG3-HRP (Southern Biotech) were then used separately to detect the presence of any natural Abs to the bacteria. 2,29-Azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) substrate was added and allowed to develop at room temperature. The plates were read at 405 nm using a Synergy H4 Hybrid reader (BioTek). Values for blanks were subtracted from sample values to get the actual OD readings.
Phagocytosis assay
The phagocytosis assay was modified from an existing protocol (27) . Live S. pneumoniae ST3 A66 were labeled with 2 3 10 26 M PKH26 (SigmaAldrich). A 1-ml frozen stock of A66 was thawed at room temperature, spun down at 13,000 rpm for 3 min, washed twice in serum-free RPMI medium (Sigma-Aldrich), and resuspended in a final volume of 500 ml Dilutant C from the PKH26 kit. Five hundred microliters of a 4 3 10 26 M solution of PKH26 in Dilutant C was added to the resuspended A66 and incubated for 3 min, protected from light, at room temperature. The PKH26-labeled A66 was spun down and washed three times with serumfree RPMI and resuspended in serum-free RPMI to a concentration of 2 3 10 7 CFU/50 ml dose. B7x 2/2 and Wt mice were anesthetized as described, and the PKH26-labeled bacteria were delivered intranasally. After a 30-min incubation, mice were euthanized as described, and bronchoalveolar lavage fluid (BALF) was collected with five 1-ml washes of cold PBS. The BALF macrophages and neutrophils were detected by FACS as described in the flow cytometry section. Phagocytosis by macrophages or neutrophils was determined by fluorescent detection of the PKH26-labeled bacteria that fluoresce at 565 nm and can be detected on a 561-or 488-nm laser in the same channel as R-PE.
Flow cytometry
Mice were deeply anesthetized and vascularly perfused with PBS through the right ventricle of the heart to remove blood from the vasculature via a puncture in the inferior vena cava. Whole lungs were collected and placed in cold digestion buffer (5% FCS, collagenase D, and heparin in plain DMEM), and broken apart using lung program 1 of the gentleMACS Dissociator (Miltenyi), incubated with gentle rotation at 37˚C for 30 min; then a single-cell suspension was prepared using lung program 2 of the gentleMACS Dissociator. Spleens were collected and placed in 4 ml cold, plain DMEM, and a single-cell suspension was prepared using spleen program 1 of the gentleMACS Dissociator. RBCs were lysed, cells were filtered, and finally resuspended to the desired concentration. Cells were preincubated with anti-CD16/CD32 (eBioscience) to block FcR binding and then stained with combinations of the following Abs: CD45-PE or PerCP, CD8a-PerCP, B220-FITC, NK1.1-biotin, CD11c-biotin, CD86-PE, CD49d-biotin, CD11b-PE (eBioscience), CD4-Alexa 488, CD62L-allophycocyanin, Ly6G-FITC (clone 1A8; BD), F4/80-Alexa Fluor 647 (AbD Serotec), or CD44-Pacific Blue (BioLegend). For intracellular staining, cells were fixed and permeabilized using the Foxp3 fixation/ permeabilization kit (eBioscience) and then stained with anti-Foxp3-PE (eBioscience). Samples were examined with the BD Biosciences LSRII flow cytometer using BD FACSDiva (BD Biosciences) software with subsequent analysis of data in FlowJo (Tree Star).
Statistical analyses
Statistical significance was calculated with the unpaired t test using Prism software version 4.0b (GraphPad). Data for survival were analyzed according to the Kaplan-Meier method, and the univariate comparison of survival for control versus knockout group was tested using a log-rank test. Analysis of CFU data, cytokine/chemokines, and cellular phenotyping analysis was performed using Student t test. A p value ,0.05 was considered statistically significant.
Results
B7x protein is expressed in the lung, but not in lymphoid tissues
Previously, B7x mRNA expression was detected in both lymphoid and peripheral nonlymphoid tissues (3) (4) (5) . However, levels in nonlymphoid tissues, such as the lung, were much higher than in lymphoid tissues (3, 6) . In this study, we used immunohistochemistry analysis to determine whether the pattern of B7x protein expression mirrors that of the existing mRNA data. We analyzed the lung and spleen of Wt mice (Fig. 1A-C, 1E, 1G ) and used both the equivalent tissues of B7x 2/2 mice (Fig. 1D, 1F, 1H ) and an isotype control Ab (Fig. 1B) as negative controls. In Wt mice, B7x protein was detected on the epithelium lining the bronchial passages of the lung, shown as the brown Ab-specific signal (Fig. 1A , 1C, 1E). Expression was not observed when an isotype control Ab was used in Wt lung (Fig. 1B) or when an anti-B7x Ab was used in tissues from B7x 2/2 mice. There was no detectable B7x protein expression in spleen of Wt (Fig. 1G) or B7x 2/2 ( Fig. 1H) mice, or in lymph nodes of both mice (data not shown). As in a previous study (6), we detected B7x protein expression specifically in the b cells of the pancreas (data not shown). This immunohistochemical staining is consistent with our recent work where B7x protein was not detected on mouse APCs before or after activation using a panel of mAbs and polyclonal Ab (6) . Collectively, these results demonstrate that, unlike other B7 molecules, endogenous B7x protein is expressed in the periphery, but not in lymphoid tissues.
B7x-deficient, but not B7-H3-deficient, mice are significantly more resistant to lethal pulmonary infection with S. pneumoniae Based on our data showing that B7x was expressed in the lungs (Fig. 1E) , we examined the outcome of pulmonary infection with S. pneumoniae in B7x 2/2 mice. We performed a dose titration in Wt mice and decided to use an inoculum of 1 3 10 5 CFU, as it was the lowest dose resulting in 100% lethality (data not shown). At this inoculum, B7x 2/2 mice were significantly more resistant to S. pneumoniae infection than Wt mice (p , 0.002); 100% of Wt mice died by day 4 postinfection, whereas 44% of B7x 2/2 mice survived for 30 d, at which time the experiment was terminated ( Fig. 2A) . Because the B7 family of proteins is phylogenetically divided into three groups, and B7x and B7-H3 make up group III (2, 3), we infected B7-H3 2/2 mice with the same inocula to determine whether the resistance phenotype was specific to B7x. Similar to Wt mice, B7-H3 2/2 mice exhibited a susceptible phenotype, and there was no significant difference in survival between B7-H3 2/2 and Wt mice (Fig. 2B ).
To determine whether the enhanced survival in B7x 2/2 mice was specific to pulmonary infection, we used a systemic i.p. challenge model (28) . When B7x 2/2 and Wt mice were i.p. infected with 1 3 10 5 CFU S. pneumoniae, 100% of both groups died within 4 d of infection (Fig. 2C) , suggesting B7x does not regulate S. pneumoniae-induced systemic infection. Taken together, these findings suggest that B7x in the lung, but not B7-H3, plays an important role in the outcome of S. pneumoniae pulmonary infection.
B7x-deficient mice exhibit better bacterial clearance in pulmonary infection
During pulmonary infection with S. pneumoniae, bacteria spread from the lung into blood and then distant organs such as spleen. Therefore, we determined the bacterial burden to assess dissemination in B7x 2/2 and Wt mice (Fig. 3) . At 6 h postinfection, both B7x 2/2 and Wt mice had similar numbers of bacteria in their lungs (Fig. 3A) . However, by 12 h postinfection, whereas Wt mice had a minimal increase in burden, B7x 2/2 mice had a significantly lower number of lung CFU (Fig. 3A) . This difference was also observed at 36 h postinfection (Fig. 3A) . Analysis of blood and spleen of these mice also revealed significantly lower CFU at 36 h in B7x 2/2 than Wt mice (Fig. 3B, 3C ). These results reveal that B7x 2/2 mice are able to better control bacterial burdens as early as 12 h postinfection. 
B7x-deficient mice have less immunopathology in lungs post pulmonary infection
We next examined lung histopathology. Both B7x 2/2 and Wt mice had normal lung tissue before infection (data not shown). However, histological analysis of lungs from B7x 2/2 and Wt mice intranasally infected with a lethal dose of S. pneumoniae showed marked differences in inflammation. At 12 h postinfection, each strain of mouse had evidence of pneumonia, which was marked by neutrophil infiltration, especially around bronchioles and in alveolar spaces (Fig. 4A , Table I ). By 36 h postinfection, inflammation in lungs of Wt mice had progressed, exhibiting severe neutrophilic perivascular inflammation with necrosis, edema, and hemorrhage, but little to no airway-associated inflammation (Fig. 4B , Table I ).
In contrast, lungs of B7x 2/2 mice exhibited an inflammatory pattern that was similar to that observed 12 h postinfection, which was minimal and airway-centric (Fig. 4C , Table I ). Only one of the four B7x 2/2 mice had a similar distribution and severity of inflammation as the Wt mice (Table I ). There were no notable differences at any time points between histopathological findings in the spleen, liver, kidney, and brain (data not shown).
B7x-deficient mice produce less inflammatory cytokines and chemokines after pulmonary infection
It has been reported that increased levels of IL-6 and CCL2 (MCP-1) are associated with S. pneumoniae-induced death (26) . Therefore, we compared production of inflammatory cytokines and chemokines between B7x 2/2 and Wt mice. The reduced inflammation observed in lungs of B7x 2/2 compared with Wt mice (Fig.   4 ) was accompanied by lower levels of proinflammatory cytokines and chemokines (Fig. 5 ). There was no significant difference in basal levels of the examined cytokines and chemokines in the lungs or serum between naive B7x 2/2 and Wt mice (Figs. 5, 6 ).
However, at 12 h postinfection, IL-6, TNF-a, and CCL2 were significantly lower in lungs of B7x 2/2 than Wt mice. There were no significant differences in IL-10 and IFN-g (Fig. 5 ). B7x
mice also had significantly lower levels of the chemokines MCP-1, KC, MIP-1a, and MIP-1b, but not RANTES (Fig. 5) . Although there was not as marked a difference in these cytokines and chemokines in the blood, at all points of statistical significance B7x 2/2 mice had lower levels than Wt mice (Fig. 6 ). These results demonstrate that B7x 2/2 mice had lower levels of inflammatory cytokines and chemokines in lungs and blood than Wt mice as early as 12 h postinfection.
Enhanced survival in B7x-deficient mice is not due to higher levels of natural Abs or phagocytosis Wt mice succumbed to intranasal infection within 4 d postinfection ( Fig. 2A) , whereas B7x 2/2 mice survived significantly beyond this point and had lower lung CFU as early as 12 h postinfection (Fig. 3A) . Because the control of infection in B7x 2/2 mice occurred at such an early time, we decided to assess the innate immune response to S. pneumoniae by evaluating natural Abs and phagocytosis. Natural Ab levels are critical for survival of S. pneumoniae-infected mice, and facilitate opsonization and phagocytic killing of bacteria by macrophages and neutrophils (29) (30) (31) .
To determine whether the enhanced survival of B7x 2/2 mice was due to a difference in their level of natural Abs, we analyzed anti- (n = 6) and Wt (n = 6) mice were infected with 1 3 10 5 CFU ST3 strain A66, and bacterial burdens were analyzed in homogenized whole tissues. S. pneumoniae IgM and IgG3 by ELISA. There was no significant difference in the level of these Abs (Fig. 7A) . We then performed an in vivo phagocytosis assay in the lungs of B7x 2/2 and Wt mice.
S. pneumoniae was labeled with the fluorescent cell dye PKH26, delivered intranasally into the lung, and after 30 min, BALF was collected for analysis by FACS for phagocytosed bacteria. There was no statistically significant difference in in vivo phagocytosis by either alveolar macrophages (Fig. 7B) or neutrophils (Fig.  7C) . Therefore, neither natural Abs to S. pneumoniae nor phagocytosis contributes to the observed resistant phenotype of B7x
mice.
Enhanced survival in B7x-deficient mice after pulmonary infection with S. pneumoniae is associated with an increase in activated T cells in lungs
Given that the enhanced bacterial clearance and survival of S. pneumoniae-infected B7x 2/2 mice could not be attributed to enhanced natural Ab or phagocytosis, we analyzed cellular infiltrates in the lung and spleen at 12 h postinfection, a time when a difference in CFU between B7x 2/2 and Wt mice was evident (Fig. 3A) . As compared with Wt mice, naive B7x 2/2 mice have no significant differences in their immune cell populations, no immunopathology, no elevation of autoantibodies, and no spontaneous autoimmune disease (6, 14, 15) . Postinfection, both strains had similar numbers of CD45 + cells in their lungs (Fig.  8A ), which were B7x protein negative (data not shown). However, B7x 2/2 mice had significantly more CD4 (Fig. 8B ) and CD8 ( (Fig. 4) . No significant difference in the number of these cells was observed in the spleen (Fig. 8E-G) . We also analyzed Foxp3 + CD4 + regulatory T cells, B cells, NK cells, dendritic cells, and macrophages in the lung (Fig. 8H) and spleen (Fig. 8I) , but there were no differences in the number of these cells between strains. In addition, at 6 h postinfection, no significant difference in the total number of neutrophils in the lungs of B7x 2/2 and Wt mice was observed (data not shown). As CD8 T cells have been shown to be required for resistance to S. pneumoniae A66 in naive C57BL/6 mice (18), and CD4 and CD8 T cells are recruited to the lung in immunized mice that are protected against a lethal challenge with A66 (24), we determined the activation state of T cells in lungs by detecting CD62L and CD44 surface markers to distinguish between naive (CD62L hi CD44 lo ) and activated (CD62L lo CD44 hi ) T cells. No significant difference in the absolute number of naive CD4 (Fig. 9A) or CD8 (Fig. 9C) T cells was observed in the lung. However, there were significantly more activated CD4 (Fig. 9B) and CD8 (Fig. 9D) 
T cells in the lung of B7x
2/2 than Wt mice, with B7x 2/2 mice having more than two times the number of cells. We also analyzed cytokines in the whole lung and found a significant, although slight, increase of IL-2 in the whole lung of B7x 2/2 mice at 12 h postinfection (Fig. 9E ), but there was no difference in IL-4, IL-17A (Fig. 9E) , or IFN-g (Fig. 5) . To support the importance of the role of T cells in controlling infection in our B7x 2/2 mice, we used B7x 2/2 Rag1 2/2 mice that lack mature T cells. B7x
Rag1 2/2 , B7x 2/2 , and Wt mice were challenged with lethal S. pneumoniae, and at 12 h postinfection, as seen in prior analyses (Fig. 3A) , B7x 2/2 mice had significantly reduced lung bacterial burden by this time point (Fig. 9F) . However, in the B7x
Rag1 2/2 mice, this reduction was no longer observed and the mice had significantly higher bacterial burdens than the B7x
that were comparable with those in the susceptible Wt mice (Fig.   9F ). These results suggest that the resistance of B7x 2/2 mice to lethal pulmonary infection may be caused by an increase in activated T cells in the lung at early time points postinfection.
Discussion
One of the most intriguing characteristics of B7x is that its mRNA expression is much higher in peripheral nonlymphoid tissues than lymphoid tissues (3, 6) . In previous studies, we could not detect B7x protein expression on DCs and macrophages under a variety of in vitro stimulatory conditions (6) . Our previous study revealed that lungs have the highest level of B7x mRNA (3), and we now extended this finding by confirming B7x protein was expressed on the bronchial epithelium of the lung, but not in the spleen. These results are consistent with clinical observations that B7x protein is expressed in human lung tissue (10) and abundantly expressed by FIGURE 5. B7x-deficient mice have reduced lung inflammatory cytokines and chemokines. B7x 2/2 (n = 6) and Wt (n = 6) mice were infected with 1 3 10 5 CFU S. pneumoniae ST3 strain A66, and cytokines and chemokines were analyzed in homogenized whole lung. For naive analysis, n = 4. Cytokine levels were analyzed in the lung in naive B7x 2/2 and Wt mice and at 12 and 36 h postinfection. B7x 2/2 mice had a reduced inflammatory response in the lung, as indicated by significantly lower amounts of IL-6 and TNF-a; there was no significant difference in IL-10 and IFN-g. The lungs were also analyzed for levels of the chemokines MCP-1, KC, MIP-1a, and MIP-1b, which were all significantly reduced in the B7x 2/2 mice; there was no significant difference for RANTES. Error bars represent SEM. For analysis of naive mice, four mice were used per group. This is representative of three separate experiments. *p , 0.05, **p , 0.01, ***p , 0.001. + non-small cell lung tumors have fewer infiltrating lymphocytes and increased lymph node metastasis (32) . Taken together, these results suggest lung-expressed B7x may contribute to disease progression by attenuating T cell function in the lung. To examine this question further, we investigated the effect of B7x on the outcome of a lethal pulmonary infection.
We found that B7x 2/2 mice were significantly more resistant to a lethal pulmonary infection with S. pneumoniae than Wt mice, and that this was accompanied by lower bacterial burdens in the lung, blood, and spleen, and markedly less lung pathology. All Wt mice died within 4 d postinfection, whereas a significant proportion of B7x 2/2 mice survived indefinitely. To determine whether the absence of B7x conferred resistance to systemic infection as well, we infected mice i.p. with a lethal dose of S. pneumoniae. However, we found that in this scenario, B7x 2/2 mice were no longer resistant to infection. Based on phylogenetic analysis, B7 proteins can be divided into three groups, and group III includes B7-H3 and B7x (3). Like B7x, B7-H3 mRNA is expressed in the lung (21, 22) . However, the physiological function of B7-H3 on T cell proliferation and cytokine production remains controversial (33, 34) . B7-H3 binds activated T cells, leading to costimulation in some cases and to coinhibition in others. Similarly, studies in B7-H3 2/2 mice support a costimulatory role in some disease models and a coinhibitory role in others (23, 35) . We infected B7-H3 2/2 mice intranasally with the same lethal dose of S. pneumoniae, but found the mice were not resistant. Therefore, B7x, but not its closest homolog B7-H3, plays an important role in disease progression in a lethal pulmonary infection. When S. pneumoniae infects the lung, the first immune cells it encounters are the resident alveolar macrophages, with subsequent recruitment of neutrophils that help phagocytose the bacterium and clear infection (16) . Although recruited neutrophils can enhance bacterial clearance, an overly exuberant inflammatory response can damage host tissue, with increasing morbidity and mortality (18, 25, 26, 31) . A damaging neutrophil response has been associated with lethality in murine S. pneumoniae infection, which was accompanied by an increase in proinflammatory factors, particularly IL-6 (18, 26, 31) . Similarly, Wt mice in our model exhibited increased levels of proinflammatory cytokines and chemokines, and succumbed rapidly to pulmonary infection. These mice also had severe necrotizing neutrophilic inflammation that was located in perivascular spaces and associated with tissue damage in the lung and dissemination of bacteria to the blood and spleen. In contrast, B7x 2/2 mice had lower levels of cytokines and mild lung inflammation that was limited to the alveolar space and no significant bloodstream dissemination. Consistent with their and C57BL/6 Wt (n = 6) mice were infected with 1 3 10 5 CFU ST3 strain A66, and immune cell infiltration was analyzed by FACS at 12 h postinfection. B7x 2/2 mice had similar numbers of CD45 + cells (A) and had significantly higher numbers of (B) CD4 + and (C) CD8 + T cells in their lungs, but significantly lower numbers of (D) neutrophils. (E-G) There was no significant difference for these cell types in the spleen. There was no significant difference in the numbers of regulatory T cells, B cells, NK cells, dendritic cells, or macrophages in either the (H) lung or the (I) spleen. Error bars represent SEM. This is representative of six separate experiments. *p , 0.05. severe lung pathology, Wt mice had significantly more neutrophils in their lungs at 12 h postinfection. Although our data show that S. pneumoniae-infected B7x 2/2 mice exhibited a resistance phenotype and had a reduced neutrophil response in lungs, another study shows that B7x 2/2 mice infected i.p. with L. monocytogenes exhibit enhanced survival and an increased neutrophil response (15) . In this infection model, B7x inhibits development of neutrophils from bone marrow progenitors, and on challenge with L. monocytogenes, the absence of B7x allows for a more numerous protective neutrophil response, which controls bacterial growth and leads to enhanced survival in their B7x 2/2 mice (15). However, at 12 h postinfection in our S. pneumoniae model, neutrophils appear to be detrimental to the host, and at 6 h postinfection, before a difference in lung bacterial burden is observed between B7x 2/2 and Wt mice, we saw no difference in the neutrophil response. This could be because of the different immune responses initiated by S. pneumoniae and L. monocytogenes and the sight of infection. After lung infection with S. pneumoniae in mice, the bacterial burden usually stagnates until ∼12 h postinfection, after which it increases (16). We found that B7x 2/2 mice had markedly lower bacterial burdens in their lungs than Wt mice. At 6 h postinfection, B7x 2/2 and Wt mice had comparable CFU in the lungs. By 12 h, Wt mice maintained a similar CFU that was significantly elevated over the following 24 h. Although CFU in Wt mice at 12 h postinfection were comparable with those at 6 h, B7x 2/2 mice had significantly fewer lung CFU at this time. Natural Abs to S. pneumoniae are important for resistance to infection (29, 30, 36) . Despite early control of infection in B7x 2/2 mice, these mice did not have increased levels of natural Ab to S. pneumoniae or an increase in phagocytosis by alveolar macrophages or neutrophils. Analysis of the immune infiltrates in lungs of intranasally infected mice revealed different cellular profiles. B7x 2/2 mice, which exhibited a resistance phenotype, had fewer neutrophils and more activated T cells, whereas Wt mice, which exhibited a susceptible phenotype, had more neutrophils and fewer T cells. We supposed that the control of infection in the B7x 2/2 mice may be because of the enhanced T cell response, and this appears to be supported by the inability of the B7x 2/2 Rag1 2/2 mice, which lack mature T cells, to reduce bacterial burdens by 12 h postinfection as the B7x 2/2 mice do. T cells have been shown to be important for bacterial clearance in colonization models (37) (38) (39) (40) , but their role in pneumonia is only recently emerging (18, 19) . HIV-infected individuals are more susceptible to S. pneumoniae pneumonia, which is associated with decreased (41) or defective (42) T cells. Murine studies show that CD4 T cells accumulate in the lung postinfection with S. pneumoniae in a manner dependent on pneumolysin, an important virulence factor of the bacterium (19, 43) . Several studies have demonstrated a role for CD4 T cells in murine models because mice lacking these cells are more susceptible to pneumonia (19) or colonization with S. pneumoniae (40) and are not protected against colonization when challenged after vaccination (37, 38, 44) . However, CD4 T cells are also shown to be detrimental or dispensable in other pneumococcal pneumonia models (18, 20) . In addition, CD8 T cells are shown to be critical for resistance to ST3 S. pneumoniae pulmonary infection because mice lacking these cells are more susceptible to death and are not protected in a vaccine challenge model (18, 45) . It is currently unclear how CD4 or CD8 T cells protect mice from respiratory infection with S. pneumoniae. In the case of CD4 T cells, it appears that the mechanism of protection may be through production of IL-17, which recruits neutrophils, as mice lacking IL-17 are more susceptible to infection with ST6B (46) and colonization with ST23F (47), although it is dispensable in a ST3 pneumonia model (18) . In the ST3 model in which CD8 T cells are required, IFN-g (18, 48) and perforin (18) are each also required for the resistance phenotype. Although IFN-g could work by activating macrophages and increasing their killing functions (49) , perforin might act by enhancing extracellular killing of S. pneumoniae as it, in addition to another cytotoxic factor produced by CD8 T cells, granzyme B, is capable of killing extracellular Mycobacterium tuberculosis (50, 51) . The enhanced T cell response and survival of B7x 2/2 mice provides in vivo support that B7x inhibits T cell responses, specifically in the lung, which contributes to the lethality of pulmonary S. pneumoniae infection. in whole lung, but no difference was seen in levels of IL-4 or IL-17A. Twelve hours postinfection, lung bacterial burdens were analyzed in B7x 2/2 Rag1 2/2 , B7x 2/2 , and Wt. As previously found (Fig. 3A) , B7x 2/2 had significantly lower CFU; however, in the B7x
